OncoPeptTUME – An in silico platform to study tumor micro-environment

Cancer immunotherapy is now established as a major therapeutic modality, and 70% of all cancer patients are estimated to receive some form of an immunotherapy treatment as a part of their disease control by 2025. Several different tumor cell-intrinsic and extrinsic features including the tumor micro...

Full description

Bibliographic Details
Main Authors: Malini Manoharan, Nitin Mandloi, Sushri Priyadarshini, Rohit Gupta, Amit Chaudhuri, Ravi Gupta
Format: Article
Language:English
Published: Science Planet Inc. 2017-12-01
Series:Canadian Journal of Biotechnology
Online Access:https://www.canadianjbiotech.com/CAN_J_BIOTECH/Archives/v1/Special Issue-Supplement/cjb.2017-a207.pdf